AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Tumor angiogenesis has no predictive value for epithelial ovarian cancer.

Women's Health Weekly

| April 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 1 - (NewsRx.com & NewsRx.net) -- Tumor angiogenesis has no predictive value for epithelial ovarian cancer.

According to scientists in Turkey, "we aimed to evaluate the prognostic significance of microvessel density (MVD), vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF-beta), as well as to find out the relationship between MVD, and VEGF and TGF-beta in epithelial ovarian cancer (EOC). Surgical specimens of 47 patients with stage I-IV primary EOC, who underwent extended surgical staging according to FIGO, were investigated. Five-micrometer thick tissue sections were immunostained with antibody to factor VIII-related antigen, and MVD was assessed at three separate areas of x200 magnification."

"Expressions for VEGF and TGF-beta were evaluated by immunohistochemical staining using related monoclonal antibodies. Results were correlated with clinicopathologic factors and survival. We did not find any correlation between MVD and clinicopathologic factors, or patient survival. Similarly, there was no association between the degree of VEGF staining and survival or clinicopathologic factors, except preoperative ascites volume, which was higher in patients showing moderate and intense VEGF staining than those with weak VEGF staining (p=0.052)," reported M. Sonmezer and colleagues, Ankara University, Tip Fak.

"The expression of TGF-beta was ...

Related articles from newspapers, magazines, journals, and more
Researchers develop first mouse model.(of epithelial ovarian cancer)
Newspaper article from: Cancer Weekly April 8, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Researchers develop first mouse model.(for epithelial ovarian cancer)
Magazine article from: Women's Health Weekly April 10, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Failure to Demonstrate Human Papillomavirus DNA in Epithelial Ovarian Cancer by.
Magazine article from: OB/GYN Clinical Alert June 1, 1999 700+ words
...Papillomavirus DNA in Epithelial Ovarian Cancer by General Primer PCR...randomly selected 98 cases of epithelial ovarian cancer from a series of 445 patients...in the development of epithelial ovarian cancer. Comment by Kenneth Noller...
Initial chemotherapy beneficial in epithelial ovarian cancer.(News)
Magazine article from: OB GYN News Lowry, Fran March 1, 2006 700+ words
...patients with advanced epithelial ovarian cancer, a retrospective comparative...Most women with advanced epithelial ovarian cancer receive initial surgery...was 85% in 98 advanced epithelial ovarian cancer patients who received...
Gemcitabine yields favorable results vs. recurrent epithelial ovarian cancer.
Newspaper article from: Cancer Weekly June 29, 2004 700+ words
...patients with recurrent epithelial ovarian cancer and yielded clinical benefit...treatment of recurrent epithelial ovarian cancer." Given the 5-year...for women with advanced epithelial ovarian cancer, Inbar and associates...
Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Cancer.
Newspaper article from: Clinical Oncology Alert November 1, 2002 700+ words
...Formulations and Risk of Epithelial Ovarian Cancer Abstract & Commentary...and the risk of invasive epithelial ovarian cancer in women participating...between any use of HRT and epithelial ovarian cancer. Although use of unopposed...
Algorithm predicts epithelial ovarian cancer risk.(WOMEN'S HEALTH)
Magazine article from: Family Practice News MacNeil, Jane Salodof April 1, 2009 700+ words
...at high or low risk for epithelial ovarian cancer based on menopausal stares...classified 94% of women with epithelial ovarian cancer in a prospective, double...disease and all stages of epithelial ovarian cancer determined ROMA's sensitivity...
Pegylated Liposomal Doxorubicin vs. Topotecan for Recurrent Epithelial Ovarian...
Magazine article from: OB/GYN Clinical Alert October 1, 2001 700+ words
...Topotecan for Recurrent Epithelial Ovarian Cancer Abstract & Commentary...patients with recurrent epithelial ovarian cancer that recurred after or...MD Once patients with epithelial ovarian cancer relapse, their curability...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA